OTC Probiotics Face Challenging Regulatory Framework
This article was originally published in The Tan Sheet
Executive Summary
The development of OTC drugs based on probiotics requires a regulatory system more receptive to research on the microorganisms' use as therapeutic ingredients, according to microbiologist Gary Huffnagle.